Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase igf1r'

Search results for: 'research area tyrosine kinase igf1r'

Items 41-50 of 245

Page
per page
  1. TAK-285
    A8528 TAK-285
    Target: EGFR|HER2
    Summary: HER2/EGFR(HER1) inhibitor
      ≥27.4 mg/mL
  2. CH5424802
    A8393 CH5424802
    Target: ALK
    Summary: ALK inhibitor,potent and ATP-competitive
  3. Silvestrol
    A3818 Silvestrol
    Summary: Antineoplastic
      Soluble in DMSO
  4. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  5. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  6. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL
  7. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  8. PD 173074
    A8253 PD 173074
    Target: VEGFR|FGFR
    Summary: FGFR inhibitor
      ≥26.18 mg/mL
  9. GNF 5
    A8604 GNF 5
    Target: Bcr-Abl
    Summary: Bcr-Abl inhibitor
  10. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O

Items 41-50 of 245

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 242item
  2. Peptides 1 item
  3. Peptides & Proteins 1 item
Reversibility
  1. Reversible 21item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 21item
  2. Akt 1 item
  3. PI3K 12item
  4. Raf 7item
  5. Aurora Kinases 13item
  6. CSF-1R 2item
  7. mTOR 6item
  8. FLT3 8item
  9. GSK-3 7item
  10. PLK 4item
  11. Chk 5item
  12. Eph Receptors 3item
  13. VEGFR 19item
  14. PDGFR 14item
  15. c-Kit 6item
  16. RET 3item
  17. IRAK 2item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. p38 6item
  20. PKB 1 item
  21. JNK 2item
  22. SGK 2item
  23. Bcr-Abl 10item
  24. MEK 4item
  25. FGFR 6item
  26. Insulin-like growth factor receptors(IGFRs) 1 item
  27. Pim 4item
  28. Ribosomal s6 kinases (RSK) 1 item
  29. MET 5item
  30. Src 8item
  31. Trk Receptors 3item
  32. STAT 1 item
  33. EGFR 10item
  34. ROCK 6item
  35. BTK 1 item
  36. PAK 3item
  37. FAK 4item
  38. BMP and Other Activin Receptors 2item
  39. JAK 9item
  40. Syk 5item
  41. DNA-PK 3item
  42. AMPK 2item
  43. PDHK 1 item
  44. ErbB 2item
  45. S6 kinases 1 item
  46. Adenosine Kinases 2item
  47. ERK 2item
  48. c-MET 5item
  49. PKC 5item
  50. Ubiquitin-specific proteases 1 item
  51. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  52. Lyn 1 item
  53. HER2 2item
  54. Pyk2 3item
  55. LRRK2 3item
  56. Insulin and Insulin-like Receptors 2item
  57. ALK 3item
  58. ROS1 1 item
  59. Sphingosine kinases (SphKs) 1 item
  60. PKG 1 item
  61. PKA 1 item
  62. Myosin light chain kinases (MLCKs) 2item
  63. CaM-KK 1 item
  64. MELK 1 item
  65. Insulin-like growth factors (IGFs) 1 item
  66. Clk 1 item
  67. NUAK1 1 item
  68. NUAK2 1 item
  69. MK2 2item
  70. Fatty-acid-binding proteins (FABPs) 1 item
  71. Tie-2 2item
  72. RSK 1 item
  73. ATM/ATR 3item
  74. CK1 1 item
  75. Farnesyl Diphosphate Synthases 1 item
  76. CK2 3item
  77. HIPK2 1 item
  78. HIPK3 1 item
  79. P2X Receptors 1 item
  80. c-Fyn 1 item
  81. TAK1 1 item
  82. P110 1 item
  83. Hck 1 item
  84. Insulin Receptors 1 item
  85. IRG-1R 1 item
  86. Cdc2-like kinase (Clk) 1 item
  87. eEF-2 1 item
  88. Cdc7 1 item
  89. ZAP-70 1 item
  90. c-RET 1 item
  91. p70 rsk 1 item
  92. TAM kinase 1 item
  93. AXL 1 item
  94. c-Fms tyrosine kinase 1 item
  95. STK 1 item
  96. MSK 1 item
  97. Lyn kinase 1 item
  98. ITK 1 item
  99. NUAK 1 item
  100. DCLK2 1 item
  101. Lck 1 item
  102. PKD 1 item
  103. tropomyosin receptor kinase 1 item
  104. SK 1 item
  105. ATM 1 item
  106. PIKfyve 1 item
  107. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 211item
  2. Cell Experiments 129item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 43item
  9. Cancer 155item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 20item
  15. Colon Carcinoma 3item
  16. Colorectal Cancer 19item
  17. Diabetes 1 item
  18. Glioblastoma 17item
  19. Glioma 6item
  20. Hepatocellular Carcinoma 4item
  21. HIV Infections 1 item
  22. Immunological Diseases 1 item
  23. Inflammatory Bowel Disease 1 item
  24. Inflammatory Diseases 4item
  25. Leukemia 7item
  26. Liver Cancer 3item
  27. Lung Cancer 15item
  28. Lung Carcinoma 3item
  29. Lymphoma 9item
  30. Mantle Cell Lymphoma 1 item
  31. Melanoma 11item
  32. Multiple Myeloma 6item
  33. Myelofibrosis 1 item
  34. Myeloma 2item
  35. Neuroblastoma 2item
  36. Non-small Cell Lung Cancer 6item
  37. Non-small Cell Lung Carcinoma 1 item
  38. Ovarian Cancer 14item
  39. Pancreatic Cancer 22item
  40. Prostate Cancer 17item
  41. Psoriasis 1 item
  42. Pulmonary Arterial Hypertension 1 item
  43. Renal Cancer 3item
  44. Renal Cell Carcinoma 5item
  45. Rheumatoid Arthritis 5item
  46. Thyroid Cancer 5item
  47. Type 2 Diabetes 3item